Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors

Drug‐induced pneumonitis risk in diffuse large B‐cell/follicular lymphoma patients treated with R‐CHOP‐like regimen is associated with the use of granulocyte colony‐stimulating growth factors

Abstract Background Rituximab‐based combinations are the standard of care in diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL). Despite being on market for over 20 years, some of the adverse effects associated with the use of rituximab are not well known. Drug‐induced interstitial p...

Full description

Bibliographic Details
Main Authors:	Elina Kaprio, Roosa Prusila, Susanna Tokola, Milla E. L. Kuusisto, Esa Jantunen, Hanne Kuitunen, Taina Turpeenniemi‐Hujanen, Outi Kuittinen
Format:	Article
Language:	English
Published:	Wiley 2024-01-01
Series:	Cancer Medicine
Subjects:	diffuse large B‐cell lymphoma drug‐induced pneumonitis follicular lymphoma granulocyte colony‐stimulating factors
Online Access:	https://doi.org/10.1002/cam4.6898

Similar Items

Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice
by: Aino Rajamaki, et al.
Published: (2024-05-01)

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients
by: Susanna Tokola, et al.
Published: (2020-03-01)

Interim and end‐of‐treatment PET‐CT suffers from high false‐positive rates in DLBCL: Biopsy is needed prior to treatment decisions
by: Susanna Tokola, et al.
Published: (2021-05-01)

Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
by: Inka Puhakka, et al.
Published: (2022-03-01)

Pulmonary T-cell lymphoma masquerading as eosinophilic pneumonitis
by: Najam Siddiqui, et al.
Published: (2019-01-01)

Rituximab-induced interstitial pneumonitis in patient with non-Hodgkin lymphoma: a clinical case
by: Nikolai A. Ognerubov, et al.
Published: (2022-08-01)

Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab
by: Kuwahara-Ota S, et al.
Published: (2018-05-01)

Clinical significance of serum anti-granulocyte–macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis
by: Kanako Katayama, et al.
Published: (2020-09-01)

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma
by: Aino Rajamäki, et al.
Published: (2023-01-01)

A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma
by: K. I. Utesheva, et al.
Published: (2023-03-01)

Optimizing Dose-Adjusted EPOCH Chemotherapy with Long-Acting Granulocyte Colony-Stimulating Factor During the COVID-19 Epidemic
by: Wei C, et al.
Published: (2021-04-01)

A case of granulocyte colony-stimulating factor producing lung adenocarcinoma with anaplastic lymphoma kinase gene rearrangements
by: Keum-Ju Choi, et al.
Published: (2023-01-01)

Interstitial lung changes and persistent COVID‐19 in a patient with follicular lymphoma: A case report
by: Makiko Yomota, et al.
Published: (2024-02-01)

An Unusual Case of Lorlatinib-Induced Pneumonitis: A Case Report
by: Philippa Kate Harrison, et al.
Published: (2022-03-01)

CD19 CAR-T Cell Therapy Induced Immunotherapy Associated Interstitial Pneumonitis: A Case Report
by: Zhuanyi Sun, et al.
Published: (2022-01-01)

Case report: Indolent drug-related pneumonitis with alectinib therapy in the treatment of non-small cell lung cancer
by: Xianmeng Chen, et al.
Published: (2022-11-01)

Handbook of granulocytes : classification, toxic materials produced and pathology /
by: Hg̃g, Reuben, et al.
Published: (2009)

The Value of Immature Granulocyte and Immature Granulocyte/Total Granulocyte Ratio in Predicting the Need for Surgical Treatment in Patients Diagnosed with Intestinal Ileus in the Emergency Department
by: Yunsur Çevik, et al.
Published: (2023-08-01)

Pneumonitis Akut dan Gagal Napas Setelah Mendapatkan Injeksi Silikon Cair di Payudara [Acute Pneumonitis and Respiratory Failure after Breast Silicon Injection: A Case Report]
by: Cut Diana Laili, et al.
Published: (2015-05-01)

Editorial: Constructing new motifs in hematology
by: Erden Atilla
Published: (2023-06-01)

Therapy Outcome of a T-Cell-Rich-B-Cell Lymphoma (TCRBCL) Patient with Rituximab-CHOP in Ibadan, Nigeria: a Case Report.
by: John Ayodele Olaniyi
Published: (2011-03-01)

Phenytoin-induced acute hypersensitivity pneumonitis
by: Pallavi Periwal, et al.
Published: (2015-01-01)

Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: Three case series
by: Yukihiro Nakamura, et al.
Published: (2021-01-01)

Real world experience of R‐CHOP with or without consolidative radiotherapy vs DA‐EPOCH‐R in the first‐line treatment of primary mediastinal B‐cell lymphoma
by: Esther Hian Li Chan, et al.
Published: (2019-08-01)

Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer
by: Zhang A, et al.
Published: (2022-08-01)

Interstitial pneumonitis during rituximab-containing chemotherapy for primary central nervous system lymphomas: a case report and review of literature
by: Yuchen Wu, et al.
Published: (2018-01-01)

Pemetrexed induced pneumonitis
by: Binod Dhakal, et al.
Published: (2011-11-01)

Complete remission of primary bilateral adrenal lymphoma achieved by Rituximab-CHOP chemotherapy
by: Yang Yin-long, et al.
Published: (2011-12-01)

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
by: Okuda R, et al.
Published: (2023-05-01)

Lymphocytic interstitial pneumonitis (LIP)-The liver and the lung
by: A. Koulaouzidis, et al.
Published: (2006-07-01)

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer
by: Xiaotong Lu, et al.
Published: (2022-06-01)

Switching to an alternative ALK-inhibitor after alectinib-induced pneumonitis resulted in resolution of this adverse event
by: Evan Bryson, et al.
Published: (2020-12-01)

No effect of pirfenidone treatment in fulminant bleomycin-induced pneumonitis
by: Elisabeth Bendstrup, et al.
Published: (2014-01-01)

Linfomas no hodgkinianos agresivos: ¿Después del CHOP sólo el CHOP?
by: Fernando Areces Delgado, et al.

Kerosene Oil Pneumonitis
by: Ranjan Kumar Singh
Published: (2021-06-01)

Acute Cytomegalovirus Pneumonitis in Patient with Lymphomatoid Granulomatosis
by: Shang-Gin Wu, et al.
Published: (2011-04-01)

A Complicated Case of Diffuse Large B-Cell Lymphoma in an Elderly Presenting with Massive Gastrointestinal Bleeding Successfully Treated with R-mini CHOP
by: Agus Jati Sunggoro, et al.
Published: (2021-03-01)

Severe measles with pneumonitis in an immunocompetent adult
by: Danielle Lee, et al.
Published: (2024-09-01)

Results of CHOP chemotherapy for diffuse large B-cell lymphoma
by: A.E. Hallack Neto, et al.
Published: (2006-10-01)

Early onset recall pneumonitis during targeted therapy with sunitinib
by: Yuasa Takeshi, et al.
Published: (2013-01-01)